| Literature DB >> 32085700 |
Yuji Shimizu1,2, Yuko Nabeshima-Kimura3, Shin-Ya Kawashiri4, Yuko Noguchi4, Yasuhiro Nagata5, Takahiro Maeda4,6, Naomi Hayashida7.
Abstract
BACKGROUND: Anti-thyroid peroxidase antibody (TPO-Ab) has been shown to cause autoimmune thyroiditis by inducing a deleterious influence on thyroid hormone synthesis. Further, thyroglobulin, which has an important role in thyroid hormone synthesis, is reported to be high in the fluid from thyroid cysts. Therefore, TPO-Ab could be associated with the presence of thyroid cyst, partly by affecting the activity of thyroid hormone synthesis.Entities:
Keywords: Anti-thyroid peroxidase antibody; Cross-sectional study; Normal thyroid function; Thyroid cysts; Thyroid hormone
Year: 2020 PMID: 32085700 PMCID: PMC7035657 DOI: 10.1186/s12199-020-00844-x
Source DB: PubMed Journal: Environ Health Prev Med ISSN: 1342-078X Impact factor: 3.674
Characteristics of the study population
| Total | Men | Women | |
|---|---|---|---|
| No. of participants | 1432 | 532 | 900 |
| No. of case (%) | 469 (32.8) | 146 (27.4) | 323 (35.9) |
| TPO-Ab, (< 16) IU/mL | 9 [7, 13]*1 | 9 [7, 12]*1 | 9 [7, 13]*1 |
| Age, year | 60.9 ± 9.0 | 62.4 ± 8.7 | 59.9 ± 9.1 |
| TSH, (0.39–4.01) μIU/mL | 1.59 [1.11, 2.28]*1 | 1.53 [1.07, 2.16]*1 | 1.61 [1.13, 2.33]*1 |
| Free T3, (2.1–4.1) pg/mL | 3.2 ± 0.3 | 3.3 ± 0.3 | 3.1 ± 0.3 |
| Free T4, (1.0–1.7) ng/dL | 1.2 ± 0.2 | 1.3 ± 0.2 | 1.2 ± 0.1 |
| BMI, kg/m2 | 22.8 ± 3.4 | 23.6 ± 3.1 | 22.4 ± 3.5 |
| SBP, mmHg | 125 ± 17 | 129 ± 14 | 123 ± 18 |
| Anti-hypertensive medication, % | 30.9 | 38.7 | 26.3 |
| HbA1c, % | 5.6 ± 0.6 | 5.7 ± 0.7 | 5.6 ± 0.6 |
| TG, mg/dL | 105 ± 73 | 123 ± 91 | 95 ± 56 |
| HDLc, mg/dL | 61 ± 15 | 54 ± 14 | 64 ± 14 |
| Menopause, % | 50.3 | – | 80.0 |
TPO-Ab anti-thyroid peroxidase antibody, TSH thyroid-stimulating hormone, free T3 free triiodothyronine, free T4 free thyroxine, BMI body mass index, SBP systolic blood pressure, TG triglycerides, HDLc high-density lipoprotein cholesterol
No. of case is the number of participants with thyroid cyst. Values are mean ± standard deviation
*1Values are median [the first quartile, third quartile]. Normal range of measurements are ( )
Thyroid-related hormone by anti-thyroid peroxidase antibody (TPO-Ab)
| Anti-thyroid peroxidase antibody (TPO-Ab) | |||
|---|---|---|---|
| − | + | ||
| Total | |||
| No. of participants | 1165 | 267 | |
| TSH, μIU/mL | 1.53 [1.09, 2.20]*1 | 1.80 [1.20, 2.66]*1 | < 0.001*2 |
| Free T3, pg/mL | 3.2 ± 0.3 | 3.2 ± 0.3 | 0.990 |
| Free T4, ng/dL | 1.2 ± 0.2 | 1.3 ± 0.2 | 0.395 |
| Men | |||
| No. of participants | 441 | 91 | |
| TSH, μIU/mL | 1.49 [1.06, 2.05]*1 | 1.75 [1.16, 2.60]*1 | 0.026*2 |
| Free T3, pg/mL | 3.3 ± 0.3 | 3.3 ± 0.3 | 0.997 |
| Free T4, ng/dL | 1.3 ± 0.2 | 1.3 ± 0.2 | 0.912 |
| Women | |||
| No. of participants | 724 | 176 | |
| TSH, μIU/mL | 1.57 [1.11, 2.28]*1 | 1.88 [1.25, 2.74]*1 | 0.005*2 |
| Free T3, pg/mL | 3.1 ± 0.3 | 3.1 ± 0.3 | 0.657 |
| Free T4, ng/dL | 1.2 ± 0.1 | 1.2 ± 0.1 | 0.148 |
TSH thyroid-stimulating hormone, free T3 free triiodothyronine, free T4 free thyroxine
Values are mean ± standard deviation
*1Values are median [the first quartile, third quartile]. *2Logarithmic transformation was used for evaluating p
Odds ratios (ORs) and 95% confidence intervals (CIs) for thyroid cyst in relation to anti-thyroid peroxidase antibody (TPO-Ab)
| Anti-thyroid peroxidase antibody | TPO-Ab (logarithmic values) | |||
|---|---|---|---|---|
| − | + | |||
| No. of participants | 1165 | 267 | ||
| No. of case | 411 (35.3) | 58 (21.7) | ||
| Model 1 | 1 | 0.47 (0.34, 0.65) | < 0.001 | 0.67 (0.58, 0.78) |
| Model 2 | 1 | 0.47 (0.34, 0.65) | < 0.001 | 0.67 (0.58, 0.78) |
| Model 3 | 1 | 0.47 (0.34, 0.65) | < 0.001 | 0.67 (0.58, 0.78) |
Model 1: adjusted for sex and age. Model 2: + TSH, free T3, free T4. Model 3: + BMI, SBP, anti-hypertensive medication, TG, HDLc, HbA1c, and for women menopause
Sex-specific odds ratios (ORs) and 95% confidence intervals (CIs) for thyroid cyst in relation to anti-thyroid peroxidase antibody (TPO-Ab)
| Anti-thyroid peroxidase antibody | p | TPO -Ab (logarithmic values) | ||
|---|---|---|---|---|
| - | + | |||
| Men | ||||
| No of participants | 441 | 91 | ||
| No. of case | 125 (28.3) | 21 (23.1) | ||
| Model 1 | 1 | 0.69 (0.40, 1.18) | 0.174 | 0.69 (0.51, 0.94) |
| Model 2 | 1 | 0.68 (0.40, 1,17) | 0.160 | 0.67 (0.49, 0.92) |
| Model 3 | 1 | 0.68 (0.40, 1.18) | 0.169 | 0.68 (0.50, 0.92) |
| Women | ||||
| No of participants | 724 | 176 | ||
| No. of case | 286 (39.5) | 37 (21.0) | ||
| Model 1 | 1 | 0.39 (0.26, 0.58) | <0.001 | 0.67 (0.56, 0.79) |
| Model 2 | 1 | 0.40 (0.27, 0.59) | <0.001 | 0.67 (0.56, 0.80) |
| Model 3 | 1 | 0.40 (0.27, 0.60) | <0.001 | 0.68 (0.57, 0.81) |
Model 1: adjusted for age. Model 2: + TSH, free T3, free T4. Model 3: + BMI, SBP, anti-hypertensive medication, TG, HDLc, HbA1c, and for women menopause